April 10, 2007
North America - East
Follow @IKCCtrials, a collaborative project of @IKCCorg, to stay up to date on #kidneycancer clinical trial news
$AVEO Oncology To Present Updated Interim Results From The Phase 2 Portion Of The TiNivo Study Of Tivozanib And Niv… t.co/csxwFJM08z
@IKCCorg’s Global Kidney Cancer Patient Survey has reached over 1500 responses across 11 languages. The survey will… t.co/rq20QS0tKQ
$AVEO Oncology Announces Initiation of Topline Analysis of Phase 3 TIVO-3 Trial t.co/JfKhIa5Gdg
Aveo Pharmaceuticals integrates a proprietary cancer biology platform with drug development and commercial expertise in its efforts to discover and develop targeted cancer therapeutics.